Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.

doi:10.1007/s00467-016-3517-z

Article

Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.

Pediatric nephrology (Berlin, Germany) - 1 Dec 2016

Hölttä Tuula, Bonthuis Marjolein, Van Stralen Karlijn J, Bjerre Anna, Topaloglu Rezan, Ozaltin Fatih, Holmberg Christer, Harambat Jerome, Jager Kitty J, Schaefer Franz, Groothoff Jaap W

Abstract excerpt

BACKGROUND: Congenital nephrotic syndrome (CNS) of the Finnish type, NPHS1, is the most severe form of CNS. Outcomes of renal replacement therapy (RRT) in NPHS1 patients in Europe were analysed using data from the ESPN/ERA-EDTA Registry. As NPHS1 is most prevalent in Finland and the therapeutic approach differs from that in many other countries, we compared outcomes in Finnish and other European patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.

Abstract excerpt

Topics

Related research